资产负债表（Aurinia Pharmaceuticals Inc）
| 2024年一季报 | 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|---|
| 截止日期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 流动资产： | |||||||||
| 现金及现金等价物(元) | 64,459,000.00 | 48,875,000.00 | 46,397,000.00 | 81,707,000.00 | 89,001,000.00 | 94,172,000.00 | 86,052,000.00 | 151,632,000.00 | 132,542,000.00 |
| 应收账款及票据(元) | 28,909,000.00 | 24,089,000.00 | 37,946,000.00 | 19,499,000.00 | 19,046,000.00 | 13,483,000.00 | 41,771,000.00 | 18,173,000.00 | 20,401,000.00 |
| 预付款项及其他应收款流动(元) | 7,646,000.00 | 9,486,000.00 | 16,158,000.00 | 11,332,000.00 | 10,096,000.00 | 13,580,000.00 | 12,159,000.00 | 17,421,000.00 | 12,199,000.00 |
| 存货(元) | 39,761,000.00 | 39,705,000.00 | 32,820,000.00 | 33,155,000.00 | 31,745,000.00 | 24,752,000.00 | 25,320,000.00 | 25,863,000.00 | 26,266,000.00 |
| 短期投资(元) | 255,453,000.00 | 301,614,000.00 | 291,503,000.00 | 269,006,000.00 | 272,533,000.00 | 295,218,000.00 | 290,592,000.00 | 240,104,000.00 | 286,210,000.00 |
| 流动资产其他项目(元) | 1,995,000.00 | 1,031,000.00 | 1,645,000.00 | 1,208,000.00 | 1,227,000.00 | 1,334,000.00 | 3,808,000.00 | - | - |
| 流动资产合计(元) | 398,223,000.00 | 424,800,000.00 | 426,469,000.00 | 415,907,000.00 | 423,648,000.00 | 442,539,000.00 | 459,702,000.00 | 453,193,000.00 | 477,618,000.00 |
| 非流动资产： | |||||||||
| 物业、厂房及设备(元) | 3,198,000.00 | 3,354,000.00 | 3,496,000.00 | 3,650,000.00 | 3,842,000.00 | 3,650,000.00 | 3,758,000.00 | 4,183,000.00 | 4,332,000.00 |
| 无形资产(元) | 4,760,000.00 | 4,977,000.00 | 5,261,000.00 | 5,683,000.00 | 6,101,000.00 | 6,425,000.00 | 6,839,000.00 | 7,338,000.00 | 7,882,000.00 |
| 长期投资(元) | 199,000.00 | 201,000.00 | 591,000.00 | - | - | - | - | - | - |
| 非流动资产其他项目(元) | 110,254,000.00 | 114,730,000.00 | 119,196,000.00 | 123,660,000.00 | 18,170,000.00 | 18,246,000.00 | 17,994,000.00 | 17,434,000.00 | 17,070,000.00 |
| 非流动资产合计(元) | 118,411,000.00 | 123,262,000.00 | 128,544,000.00 | 132,993,000.00 | 28,113,000.00 | 28,321,000.00 | 28,591,000.00 | 28,955,000.00 | 29,284,000.00 |
| 总资产(元) | 516,634,000.00 | 548,062,000.00 | 555,013,000.00 | 548,900,000.00 | 451,761,000.00 | 470,860,000.00 | 488,293,000.00 | 482,148,000.00 | 506,902,000.00 |
| 流动负债： | |||||||||
| 融资租赁负债流动(元) | 14,723,000.00 | 15,598,000.00 | 14,308,000.00 | 14,970,000.00 | 945,000.00 | 936,000.00 | 918,000.00 | 953,000.00 | 1,009,000.00 |
| 应付账款及票据(元) | 50,270,000.00 | 54,389,000.00 | 52,309,000.00 | 41,375,000.00 | 35,965,000.00 | 39,990,000.00 | 40,123,000.00 | 32,380,000.00 | 32,327,000.00 |
| 递延收入流动(元) | 4,909,000.00 | 4,813,000.00 | 4,662,000.00 | 3,228,000.00 | 3,157,000.00 | 3,148,000.00 | - | - | - |
| 流动负债其他项目(元) | 1,150,000.00 | 2,388,000.00 | 2,611,000.00 | 2,088,000.00 | 1,979,000.00 | 2,033,000.00 | 724,000.00 | 1,293,000.00 | 502,000.00 |
| 流动负债合计(元) | 71,052,000.00 | 77,188,000.00 | 73,890,000.00 | 61,661,000.00 | 42,046,000.00 | 46,107,000.00 | 41,765,000.00 | 34,626,000.00 | 33,838,000.00 |
| 非流动负债： | |||||||||
| 融资租赁负债非流动(元) | 73,814,000.00 | 82,009,000.00 | 78,906,000.00 | 86,236,000.00 | 6,986,000.00 | 7,152,000.00 | 7,270,000.00 | 7,431,000.00 | 7,562,000.00 |
| 非流动负债其他项目(元) | - | - | - | - | - | - | - | 16,323,000.00 | 17,379,000.00 |
| 非流动负债合计(元) | 86,106,000.00 | 92,920,000.00 | 89,246,000.00 | 94,947,000.00 | 19,307,000.00 | 19,318,000.00 | 23,103,000.00 | 23,754,000.00 | 24,941,000.00 |
| 总负债(元) | 157,158,000.00 | 170,108,000.00 | 163,136,000.00 | 156,608,000.00 | 61,353,000.00 | 65,425,000.00 | 64,868,000.00 | 58,380,000.00 | 58,779,000.00 |
| 股东权益： | |||||||||
| 普通股(元) | 1,207,982,000.00 | 1,200,218,000.00 | 1,198,560,000.00 | 1,196,480,000.00 | 1,193,019,000.00 | 1,185,309,000.00 | 1,184,020,000.00 | 1,180,884,000.00 | 1,178,807,000.00 |
| 股本溢价(元) | 105,419,000.00 | 120,788,000.00 | 109,711,000.00 | 98,832,000.00 | 88,885,000.00 | 85,489,000.00 | 79,188,000.00 | 74,004,000.00 | 64,686,000.00 |
| 留存收益(元) | -953,071,000.00 | -942,322,000.00 | -915,447,000.00 | -902,000,000.00 | -890,508,000.00 | -864,302,000.00 | -838,256,000.00 | -829,267,000.00 | -793,752,000.00 |
| 累计其他全面收益(元) | -854,000.00 | -730,000.00 | -947,000.00 | -1,020,000.00 | -988,000.00 | -1,061,000.00 | -1,527,000.00 | -1,853,000.00 | -1,618,000.00 |
| 归属于母公司股东权益(元) | 359,476,000.00 | 377,954,000.00 | 391,877,000.00 | 392,292,000.00 | 390,408,000.00 | 405,435,000.00 | 423,425,000.00 | 423,768,000.00 | 448,123,000.00 |
| 股东权益合计(元) | 359,476,000.00 | 377,954,000.00 | 391,877,000.00 | 392,292,000.00 | 390,408,000.00 | 405,435,000.00 | 423,425,000.00 | 423,768,000.00 | 448,123,000.00 |
| 负债及股东权益合计(元) | 516,634,000.00 | 548,062,000.00 | 555,013,000.00 | 548,900,000.00 | 451,761,000.00 | 470,860,000.00 | 488,293,000.00 | 482,148,000.00 | 506,902,000.00 |
| 公告日期 | 2024-05-02 | 2024-02-15 | 2023-11-02 | 2023-08-03 | 2023-05-04 | 2023-02-28 | 2022-11-03 | 2022-08-04 | 2022-05-10 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | |||||||||
| 核数师 |